Sanstar re-publishes EGM notice for preferential issue
Sanstar Limited has re-published a newspaper advertisement regarding its EGM scheduled for June 20, 2026, via VC/OAVM. The meeting seeks shareholder approval for a preferential issue of equity shares worth ₹198.3 crores at ₹110 per share to Corn Products Development Inc. The proceeds will fund working capital and general corporate purposes in FY 2026-27, with Acuité Ratings & Research Limited appointed as the monitoring agency. Additionally, the company is forming a joint venture with Ingredion India and Amishi Drugs for specialty ingredients.

*this image is generated using AI for illustrative purposes only.
Sanstar Limited has re-published a newspaper advertisement in the Financial Express (Gujarati) on June 1, 2026, intimating shareholders about its Extraordinary General Meeting (EGM). The EGM is scheduled on June 20, 2026, at 11:00 a.m. IST through Video Conferencing or Other Audio Visual Means (VC/OAVM) to seek approval for a preferential issue of equity shares aggregating to ₹198.3 crores. The issue is priced at ₹110 per equity share, including a premium of ₹108, and is directed towards Corn Products Development Inc., a wholly owned subsidiary of Ingredion Incorporated. Post-allotment, the investor will hold approximately 9.0% stake in the company.
The Board of Directors approved the proposal on May 28, 2026. The proceeds are intended for working capital requirements and general corporate purposes, with deployment expected in FY 2026-27. As the issue size exceeds ₹100 crores, Acuité Ratings & Research Limited has been appointed as the monitoring agency to oversee fund utilization in accordance with SEBI regulations. The company has also proposed increasing its authorized share capital from ₹38 crores to ₹50 crores to facilitate this fundraise.
The remote e-voting facility will commence on June 17, 2026, at 9:00 a.m. IST and conclude on June 19, 2026, at 5:00 p.m. IST. Shareholders recorded in the register of members or beneficial owners as on the cut-off date of June 15, 2026, are entitled to vote. The advertisement was disclosed to the exchanges under Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Transaction Summary
| Parameter | Details |
|---|---|
| Nature of Issue | Preferential Allotment of Equity Shares |
| Allottee | Corn Products Development Inc. |
| Issue Size | ₹198.3 crores |
| Price per Share | ₹110 |
| Post-Issue Stake | ~9.0% |
| Regulatory Approval | EGM and Stock Exchanges |
Joint Venture Overview
| Parameter | Details |
|---|---|
| Partners | Sanstar, Ingredion India, Amishi Drugs |
| Scope | Specialty ingredients excipients for pharma and others |
| Governance | Joint Board / Management Committee |
| Target Operations | 30-36 months post-incorporation |
Simultaneously, Sanstar and Ingredion have executed a definitive shareholders’ agreement to establish a jointly owned entity in India for the manufacture, sale, and distribution of specialty pharmaceutical and other specialty ingredient products. The Joint Venture partners include Sanstar, Ingredion India Private Limited, and Amishi Drugs and Chemicals Private Limited. The proposed entity will be incorporated as a private limited company, with manufacturing locations shortlisted in Gujarat and Maharashtra. Commercial operations are targeted within 30 to 36 months of incorporation, subject to applicable approvals.
Historical Stock Returns for Sanstar
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.18% | +0.82% | +14.43% | +26.21% | +27.23% | +0.01% |
How will the strategic partnership with Ingredion influence Sanstar's product diversification and competitive positioning in the specialty ingredients market?
What are the anticipated revenue contributions from the proposed joint venture once commercial operations commence in 30-36 months?
How does the company plan to utilize the ₹198.3 crore working capital infusion to drive growth before the joint venture becomes operational?


































